BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34130695)

  • 21. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1).
    Vlachodimou A; Konstantinopoulou K; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2020 Feb; 172():113747. PubMed ID: 31830468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice.
    Endres CJ; Moss AM; Govindarajan R; Choi DS; Unadkat JD
    J Pharmacol Exp Ther; 2009 Oct; 331(1):287-96. PubMed ID: 19602549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS.
    Bai M; Shen Q; Wu Y; Ma Z; Wang Y; Chen M; Liu D; Zhou L
    J Pharm Biomed Anal; 2024 May; 247():116268. PubMed ID: 38823222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA.
    Reyes G; Nivillac NM; Karim MZ; Desouza L; Siu KW; Coe IR
    Mol Membr Biol; 2011 Sep; 28(6):412-26. PubMed ID: 21809900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
    Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
    Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
    Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1.
    Osato DH; Huang CC; Kawamoto M; Johns SJ; Stryke D; Wang J; Ferrin TE; Herskowitz I; Giacomini KM
    Pharmacogenetics; 2003 May; 13(5):297-301. PubMed ID: 12724623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells.
    Li Y; Lin J; Huang Y; Li Y; Yang X; Wu H; Wu S; Xie L; Dai L; Hou Z
    ACS Appl Mater Interfaces; 2015 Nov; 7(46):25553-9. PubMed ID: 26529185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines.
    Chen X; Xue Y; Wang L; Weng Y; Li S; Lü W; Xie X; Cheng X
    Bioengineered; 2022 Feb; 13(2):2076-2086. PubMed ID: 35038949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.
    Yamamoto T; Kuniki K; Takekuma Y; Hirano T; Iseki K; Sugawara M
    Eur J Pharmacol; 2007 Feb; 557(1):1-8. PubMed ID: 17140564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
    Grenz A; Bauerle JD; Dalton JH; Ridyard D; Badulak A; Tak E; McNamee EN; Clambey E; Moldovan R; Reyes G; Klawitter J; Ambler K; Magee K; Christians U; Brodsky KS; Ravid K; Choi DS; Wen J; Lukashev D; Blackburn MR; Osswald H; Coe IR; Nürnberg B; Haase VH; Xia Y; Sitkovsky M; Eltzschig HK
    J Clin Invest; 2012 Feb; 122(2):693-710. PubMed ID: 22269324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [cDNA microarray analysis of gene expression in acquired methotrexate-resistant of human choriocarcinoma].
    Chen YX; Xie X; Cheng Q
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):396-9. PubMed ID: 15312324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
    Endres CJ; Moss AM; Ishida K; Govindarajan R; Unadkat JD
    Biopharm Drug Dispos; 2016 Sep; 37(6):336-44. PubMed ID: 27194214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes.
    Endres CJ; Moss AM; Ke B; Govindarajan R; Choi DS; Messing RO; Unadkat JD
    J Pharmacol Exp Ther; 2009 Apr; 329(1):387-98. PubMed ID: 19164463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.